AMAG Pharmaceuticals (AMAG) PT Raised to $24 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/20/2026
- Wall St hits two-week lows as rising bond yields, Walmart results drag
- Walmart shares fall despite earnings beat
- Alibaba stock dips as Q2 profit misses estimates despite strong AI cloud growth
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Moderna stock pulls back after massive one-day rally: analysts weigh in
- Marvell issues Google warrant tied to custom chip deal
- FOMC minutes from July 28-29th meeting
- US stock futures steady after tech slump; investors focus on Middle East tensions
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
AMAG Pharmaceuticals (AMAG) PT Raised to $20 at Piper Jaffray
February 28, 2018 3:06 AM ESTPiper Jaffray raised its price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $20.00 (from $18.00) while maintaining a Neutral rating.
... MoreAMAG Pharmaceuticals (AMAG) PT Raised to $21 at Leerink Partners
February 28, 2018 2:43 AM ESTLeerink Partners raised its price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $21.00 (from $13.00) while maintaining a Market Perform rating.
... MoreAMAG Pharmaceuticals (AMAG) PT Raised to $25 at Cowen as Execution Improves
February 27, 2018 11:59 AM ESTCowen raised its price target on AMAG Pharmaceuticals (NASDAQ: AMAG) to $25.00 (from $20.00) while maintaining a Market Perform rating.
Analyst Ken Cacciatore commented, "AMAG has had a very nice start to '18, with the Makena autoinjector approval a solid step in the recovery. While... More
